Scholtz & Company’s CyrusOne Inc Common Stock CONE Stock Holding History

Scholtz & Company’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-40,735	Closed	-$1.86M	–	45
2016 Q1	$1.86M	Buy	+40,735	New	+$1.56M	1.86%	25

Other funds holding CONE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

Scholtz & Company's CONE Position: Q2 2016 in Review

Scholtz & Company sold out of CyrusOne Inc Common Stock (CONE) in Q2 2016, closing a stake of 40,735 shares — an estimated $1.86M sold.

Scholtz & Company first reported a position in CONE in Q1 2016 and held it in 1 quarter. The position peaked at $1.86M in Q1 2016. 282 funds tracked by Wall St. Rank hold CONE as of Q2 2016.

Scholtz & Company reported no remaining CyrusOne Inc Common Stock position as of Q2 2016 after selling out during the quarter.
Scholtz & Company sold 40,735 CyrusOne Inc Common Stock shares in Q2 2016, an estimated $1.86M.
Scholtz & Company first reported a position in CyrusOne Inc Common Stock in Q1 2016 and held it in 1 quarter.
Scholtz & Company's CyrusOne Inc Common Stock position peaked at $1.86M in Q1 2016.
282 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q2 2016.

Based on Scholtz & Company's 13F filing for Q2 2016, filed 15 Aug 2016.